Bausch Health Cos., Inc. (BHC)
6.415
+0.10
(+1.50%)
USD |
NYSE |
Oct 20, 16:00
6.415
0.00 (0.00%)
After-Hours: 19:43
Bausch Health Cos. Market Cap : 2.399B for Oct. 20, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 19, 2026 | 2.363B |
| October 16, 2026 | 2.356B |
| October 15, 2026 | 2.359B |
| October 14, 2026 | 2.202B |
| October 13, 2026 | 2.202B |
| October 12, 2026 | 2.217B |
| October 09, 2026 | 2.258B |
| October 08, 2026 | 2.258B |
| October 07, 2026 | 2.299B |
| October 06, 2026 | 2.251B |
| October 05, 2026 | 2.202B |
| October 02, 2026 | 2.169B |
| October 01, 2026 | 2.142B |
| September 30, 2026 | 2.180B |
| September 29, 2026 | 2.169B |
| September 28, 2026 | 2.157B |
| September 25, 2026 | 2.127B |
| September 24, 2026 | 2.113B |
| September 23, 2026 | 2.135B |
| September 22, 2026 | 2.172B |
| September 21, 2026 | 2.109B |
| September 18, 2026 | 2.120B |
| September 17, 2026 | 2.113B |
| September 16, 2026 | 2.127B |
| September 15, 2026 | 2.120B |
| Date | Value |
|---|---|
| September 14, 2026 | 2.213B |
| September 11, 2026 | 2.191B |
| September 10, 2026 | 2.270B |
| September 09, 2026 | 2.303B |
| September 08, 2026 | 2.404B |
| September 04, 2026 | 2.453B |
| September 03, 2026 | 2.528B |
| September 02, 2026 | 2.554B |
| September 01, 2026 | 2.419B |
| August 31, 2026 | 2.382B |
| August 28, 2026 | 2.363B |
| August 27, 2026 | 2.356B |
| August 26, 2026 | 2.434B |
| August 25, 2026 | 2.516B |
| August 24, 2026 | 2.498B |
| August 21, 2026 | 2.408B |
| August 20, 2026 | 2.546B |
| August 19, 2026 | 2.576B |
| August 18, 2026 | 2.591B |
| August 17, 2026 | 2.460B |
| August 14, 2026 | 2.434B |
| August 13, 2026 | 2.371B |
| August 12, 2026 | 2.322B |
| August 11, 2026 | 2.333B |
| August 10, 2026 | 2.374B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| InMed Pharmaceuticals, Inc. | 7.155M |
| NervGen Pharma Corp. | 164.41M |
| Milestone Pharmaceuticals, Inc. | 88.80M |
| Appili Therapeutics, Inc. | 0.9001M |
| Clearmind Medicine, Inc. | 12.96M |
Market Cap Related Metrics
| PS Ratio | 0.2212 |
| Price to Free Cash Flow | 1.743 |
| Price | 6.415 |
| Earnings Yield | -46.15% |
| Operating PE Ratio | 0.8787 |
| Normalized PE Ratio | 11.79 |